Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 臺北市中正區忠孝西路一段66號23、24樓 (86927438) - lamotrigine - 咀嚼錠 - 主成分 () ; lamotrigine (2812001600) mg - lamotrigine - 1. 癲癇(泛發性強直陣攣性發作及簡單性或複雜性局部發作)成人與12歲以上兒童之單獨用藥治療；成人與2歲以上兒童之輔助性治療。2. 成人與2歲以上兒童lennox-gastaut syndrome徵候群癲癇發作之輔助治療。

Ċina - Ċiniż - CFDA (药监局 - 中国食品和药物管理局)

aspen pharma trading limited - 苯磺顺阿曲库铵 - 注射剂 - 5ml:10mg

Ċina - Ċiniż - CFDA (药监局 - 中国食品和药物管理局)

aspen pharma trading limited - 米库氯铵 - 注射剂 - 5ml:10mg

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238);;a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227);;b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26);;b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) - 滅菌懸液注射劑 - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238) (8012002540) ug ha; b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) (8012006210) ug ha; b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26) (8012006270) ug ha; a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227) (8012018070) ug ha - influenza, inactivated, split virus or surface antigen - fluarix tetra是一種四價流感疫苗，適用於成人及6個月大以上之兒童的主動免疫接種，藉以預防此疫苗所涵蓋之a型與b型流感病毒所引起的流感相關疾病。

Ċina - Ċiniż - CFDA (药监局 - 中国食品和药物管理局)

pfizer ireland pharmaceuticals - 头孢他啶；阿维巴坦钠 - 注射剂 - 2.5g(c22h22n6o7s2 2.0g与c7h11n3o6s 0.5g )

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - pertussis toxoid;;diphtheria toxoid;;tetanus toxoid;;pertactin;;filamentous haemagglutinin;;r-dna hepatitis b surface antigen adsorbed (hbsag);;inactivated polio virus -type 1;;inactivated polio virus - type 2;;inactivated polio virus -type 3;;conjugated of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid (t), adsorbed - 凍晶注射劑 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) i.u.; tetanus toxoid (8008000200) i.u.; inactivated polio virus -type 1 (8012003100) du; inactivated polio virus - type 2 (8012003200) du; inactivated polio virus -type 3 (8012003300) du; conjugated of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid (t), adsorbed (8012004000) (10up of prp and 20-; r-dna hepatitis b surface antigen adsorbed (hbsag) (8081223400) ug; filamentous haemagglutinin (9200050300) ug; pertactin (9900066600) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b - infanrix hexa 適用於6週大以上之嬰兒及幼童的基礎免疫接種及追加接種，以對抗白喉、破傷風、百日咳、b型肝炎、小兒麻痺及b型嗜血桿菌。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953);;recombinant neisseria meningitidis group b nada protein (rp961c);;recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741);;outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 - 懸浮注射液 - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953) (8008004010) mcg; recombinant neisseria meningitidis group b nada protein (rp961c) (8008004020) mcg; recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741) (8008004030) mcg; outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 (8008004040) mcg - meningococcus b, multicomponent vaccine - 適用於2個月以上兒童及成人之主動免疫接種，以預防b型奈瑟氏腦膜炎雙球菌所引起的侵入性腦膜炎雙球菌疾病。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - abacavir sulfate;;lamivudine;;zidovudine - 錠劑 - 主成分 () ; zidovudine (0818000600) mg; lamivudine (0818001400) mg; abacavir sulfate (0818001610) mg - zidovudine, lamivudine and abacavir - 治療成人的人類免疫缺乏病毒之感染。

Tajwan - Ċiniż - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - a/california/7/2009(h1n1)v-like virus;;squalene;;tocopherol alpha dl- (eq to dl-alpha tocopherol);;tween 80 (eq to polysorbate 80) - 懸浮注射劑 - a/california/7/2009(h1n1)v-like virus (8012002473) ug ha; tocopherol alpha dl- (eq to dl-alpha tocopherol) (8820000113) mg; tween 80 (eq to polysorbate 80) (9600023580) mg; squalene (9600030000) mg - influenza, inactivated, split virus or surface antigen - 預防新型流感。

Ċina - Ċiniż - CFDA (药监局 - 中国食品和药物管理局)

glaxosmithkline australia pty ltd - 片剂 - 每片含盐酸二甲双胍0.5g与马来酸罗格列酮2mg(以罗格列酮计)